China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)

Market Cap	11.06B -24.3%
Revenue (ttm)	1.96B +15.1%
Net Income	327.25M +75.8%
EPS	0.65 +76.2%
Shares Out	504.25M
PE Ratio	33.73
Forward PE	19.34
Dividend	0.30 (1.34%)
Ex-Dividend Date	Sep 26, 2025

Volume	5,497,167
Average Volume	5,388,441
Open	22.32
Previous Close	22.32
Day's Range	21.91 - 22.37
52-Week Range	21.93 - 30.76
Beta	0.22
RSI	38.59
Earnings Date	Mar 21, 2026

About SHE:300294

China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the blood product businesses in China. It offers blood products, such as human coagulation, human prothrombin, human fibrinogen, human albumin, intravenous human immunoglobulin, and rabies immunoglobulin; and non-blood products. The company also provides bone peptide, oxytocin, heparin sodium, and posterior pituitary injection products. In addition, it engages in research, development, production, and sales of anti-infective, diabetes, and cardiovascular drug; and distributes bloo...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1993
• Employees: 1,938
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300294

Financial Performance

In 2024, SHE:300294's revenue was 1.73 billion, a decrease of -34.58% compared to the previous year's 2.65 billion. Earnings were 396.99 million, an increase of 67.18%.